4.8 Review

Monitoring the dynamics of T cell clonal diversity using recombinant peptide:MHC technology

期刊

FRONTIERS IN IMMUNOLOGY
卷 4, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2013.00170

关键词

kinetics; 2D assays; T cell activation; recombinant pMHC; T cell affinity

资金

  1. NIH [1R01AI096879, 5R01NS071518]
  2. National Multiple Sclerosis Society FG [1963A1/1]

向作者/读者索取更多资源

The capacity to probe antigen specific T cells within the polyclonal repertoire has been revolutionized by the advent of recombinant peptide:MHC (pMHC) technology. Monomers and multimers of pMHC molecules can enrich for and identify antigen specific T cells to elucidate the contributions of T cell frequency, localization, and T cell receptor (TCR) affinity during immune responses. Two-dimensional (2D) measurements of TCR pMHC interactions are at the forefront of this field because the biological topography is replicated such thatTCR and pMHC are membrane anchored on opposing cells, allowing for biologically pertinent measures of TCR antigen specificity and diversity. 2D measurements of TCR-pMHC kinetics have also demonstrated increased fidelity compared to three-dimensional surface plasmon resonance data and are capable of detecting T cell affinities that are below the detection level of most pMHC multimers. Importantly, 2D techniques provide a platform to evaluate T cell affinity and antigen specificity against multiple protein epitopes within the polyclonal repertoire directly ex vivo from sites of ongoing immune responses. This review will discuss how antigen specific pMHC molecules, with a focus on 2D technologies, can be used as effective tools to evaluate the range of TCR affinities that comprise an immune response and more importantly how the breadth of affinities determine functional outcome against a given exposure to antigen.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory

Alexander P. R. Bally, Yan Tang, Joshua T. Lee, Benjamin G. Barwick, Ryan Martinez, Brian D. Evavold, Jeremy M. Boss

JOURNAL OF IMMUNOLOGY (2017)

Article Immunology

NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease

Lori Blanchfield, Joseph J. Sabatino, Laurel Lawrence, Brian D. Evavold

JOURNAL OF IMMUNOLOGY (2017)

Article Immunology

CD4 T Cell Affinity Diversity Is Equally Maintained during Acute and Chronic Infection

Rakieb Andargachew, Ryan J. Martinez, Elizabeth M. Kolawole, Brian D. Evavold

JOURNAL OF IMMUNOLOGY (2018)

Article Immunology

T Cell Receptor-Major Histocompatibility Complex Interaction Strength Defines Trafficking and CD103+ Memory Status of CD8 T Cells in the Brain

Anna Sanecka, Nagisa Yoshida, Elizabeth Motunrayo Kolawole, Harshil Patel, Brian D. Evavold, Eva-Maria Frickel

FRONTIERS IN IMMUNOLOGY (2018)

Article Endocrinology & Metabolism

A Hybrid Insulin Epitope Maintains High 2D Affinity for Diabetogenic T Cells in the Periphery

Baoyu Liu, Jennifer D. Hood, Elizabeth M. Kolawole, Derek M. Woodruff, Dario A. Vignali, Maria Bettini, Brian D. Evavold

DIABETES (2020)

Article Endocrinology & Metabolism

A Critical Insulin TCR Contact Residue Selects High-Affinity and Pathogenic Insulin-Specific T Cells

Maria Bettini, Marissa A. Scavuzzo, Baoyu Liu, Elizabeth Kolawole, Lin Guo, Brian D. Evavold, Malgorzata Borowiak, Matthew L. Bettini

DIABETES (2020)

Article Engineering, Biomedical

Localized hydrogel delivery of dendritic cells for attenuationof multiplesclerosis in a murine model

Aline M. Thomas, Nicholas M. Beskid, Jennifer L. Blanchfield, Aaron M. Rosado, Andres J. Garcia, Brian D. Evavold, Julia E. Babensee

Summary: The study demonstrated that local delivery of DC10s modulates immune cell recruitment and attenuates disease progression in a preclinical model of MS.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2021)

Article Immunology

IL-21 from high-affinity CD4 T cells drives differentiation of brain-resident CD8 T cells during persistent viral infection

Heather M. Ren, Elizabeth M. Kolawole, Mingqiang Ren, Ge Jin, Colleen S. Netherby-Winslow, Quinn Wade, Shwetank, Ziaur S. M. Rahman, Brian D. Evavold, Aron E. Lukacher

SCIENCE IMMUNOLOGY (2020)

Article Immunology

Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1 diabetes

Heejoo Kim, Jelena Perovanovic, Arvind Shakya, Zuolian Shen, Cody N. German, Andrea Ibarra, Jillian L. Jafek, Nai-Pin Lin, Brian D. Evavold, Danny H-C Chou, Peter E. Jensen, Xiao He, Dean Tantin

Summary: Loss of T cell-specific OCA-B protects mice from spontaneous autoimmune diabetes by reducing CD8(+) T cell receptor specificities associated with diabetes pathogenesis. The protective effect is recapitulated using autoantigen-specific NY8.3 mice but diminished in monoclonal models specific to artificial or neoantigens. Rational design of membrane-penetrating OCA-B peptide inhibitors normalizes glucose levels and reduces T cell infiltration and proinflammatory cytokine expression in newly diabetic NOD mice.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Endocrinology & Metabolism

Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Stephen E. Gitelman, Brian N. Bundy, Ele Ferrannini, Noha Lim, J. Lori Blanchfield, Linda A. DiMeglio, Eric Felner, Jason L. Gaglia, Peter A. Gottlieb, S. Alice Long, Andrea Mari, Raghavendra G. Mirmira, Philip Raskin, Srinath Sanda, Eva Tsalikian, John M. Wentworth, Steven M. Willi, Jeffrey P. Krischer, Jeffrey A. Bluestone

Summary: Imatinib was shown to preserve beta-cell function at 12 months in patients with recent-onset type 1 diabetes, but the effect was not sustained at 24 months. Adverse events were more common in the imatinib group compared to the placebo group, with gastrointestinal issues and laboratory investigations being the most commonly reported. Further research is needed to determine the ideal dose and duration of therapy, safety and efficacy in children, and the potential of imatinib to delay or prevent progression to diabetes.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Article Multidisciplinary Sciences

The magnitude of LFA-1/ICAM-1 forces fine-tune TCR-triggered T cell activation

Victor Pui-Yan Ma, Yuesong Hu, Anna Kellner, Joshua M. Brockman, Arventh Velusamy, Aaron T. Blanchard, Brian D. Evavold, Ronen Alon, Khalid Salaita

Summary: T cells defend against cancer and viral infections by binding to specific peptide antigens on target cells. It has been found that the forces transmitted through the LFA-1 /ICAM-1 complex can tune T cell signaling and enhance T cell activation and TCR discrimination.

SCIENCE ADVANCES (2022)

Article Immunology

Immunogen-Specific Strengths and Limitations of the Activation-Induced Marker Assay for Assessing Murine Antigen-Specific CD4+T Cell Responses

Nguyen X. Nguyen, Andrew W. Richens, Linda M. Sircy, Denise E. Allard, Elizabeth M. Kolawole, Brian D. Evavold, Maria Bettini, J. Scott Hale

Summary: The AIM assay is a cytokine-independent technique for identifying Ag-specific T cells based on upregulated expression of activation markers after Ag restimulation. This study analyzed immune responses of TCR-transgenic CD4+ T cells and found that the AIM assay is effective for identifying the frequency of protein immunization-induced effector and memory CD4+ T cells but has limitations in identifying cells induced by viral infection, especially chronic infection. The findings suggest that the AIM assay is a useful tool for quantifying murine Ag-specific CD4+ T cells in protein vaccination.

JOURNAL OF IMMUNOLOGY (2023)

Article Engineering, Biomedical

Memory in repetitive protein-protein interaction series

Aaron M. Rosado, Yan Zhang, Hyun-Kyu Choi, Yunfeng Chen, Samuel M. Ehrlich, Fengzhi Jin, Arash Grakoui, Brian D. Evavold, Cheng Zhu

Summary: Protein-protein interactions play a crucial role in coordinating biological processes and can affect an organism's responses to changing environments and diseases. In this study, we discuss memory effects in repetitive protein-protein interactions and propose several mathematical models for quantitatively analyzing these effects. We found that interactions between cell membrane proteins and peptide-major histocompatibility complex exhibit short-term memory, while peptide dissociation from MHC results in intermediate- and long-term memories. This research provides valuable insights into the mechanisms of protein interactions and can aid future studies.

APL BIOENGINEERING (2023)

Correction Oncology

Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells (vol 67, pg 311, 2018)

Tamson Moore, Courtney Regan Wagner, Gina M. Scurti, Kelli A. Hutchens, Constantine Godellas, Ann Lau Clark, Elizabeth Motunrayo Kolawole, Lance M. Hellman, Nishant K. Singh, Fernando A. Huyke, Siao-Yi Wang, Kelly M. Calabrese, Heather D. Embree, Rimas Orentas, Keisuke Shirai, Emilia Dellacecca, Elizabeth Garrett-Mayer, Mingli Li, Jonathan M. Eby, Patrick J. Stiff, Brian D. Evavold, Brian M. Baker, I. Caroline Le Poole, Boro Dropulic, Joseph I. Clark, Michael I. Nishimura

CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)

Article Oncology

Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells

Tamson Moore, Courtney Regan Wagner, Gina M. Scurti, Kelli A. Hutchens, Constantine Godellas, Ann Lau Clark, Elizabeth Motunrayo Kolawole, Lance M. Hellman, Nishant K. Singh, Fernando A. Huyke, Siao-Yi Wang, Kelly M. Calabrese, Heather D. Embree, Rimas Orentas, Keisuke Shirai, Emilia Dellacecca, Elizabeth Garrett-Mayer, Mingli Li, Jonathan M. Eby, Patrick J. Stiff, Brian D. Evavold, Brian M. Baker, I. Caroline Le Poole, Boro Dropulic, Joseph I. Clark, Michael I. Nishimura

CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)

暂无数据